Market Cap : 2.67 B | Enterprise Value : 2.23 B | PE Ratio : 26.79 | PB Ratio : 5.09 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics's other current liabilities for the quarter that ended in Dec. 2020 was $10.1 Mil.
Corcept Therapeutics's quarterly other current liabilities increased from Jun. 2020 ($5.6 Mil) to Sep. 2020 ($7.7 Mil) and increased from Sep. 2020 ($7.7 Mil) to Dec. 2020 ($10.1 Mil).
Corcept Therapeutics's annual other current liabilities increased from Dec. 2018 ($7.9 Mil) to Dec. 2019 ($12.3 Mil) but then declined from Dec. 2019 ($12.3 Mil) to Dec. 2020 ($10.1 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
No Headline